Logo (pure-white background + navy borde
  • YouTube
  • Facebook
  • Twitter
  • Instagram

© 2020 Diverse Health Hub, LLC

What Steps Can Patients Take To Detect Renal Medullary Carcinoma Early?

Dr. Pavlos Msaouel breaks down the steps patients can take to detect Renal Medullary Carcinoma (RMC) early. Dr. Msaouel identifies the complexity of the issue due to data that is still being gathered. He also points out that early detection of RMC is not easy and that it comes with pros and cons. This is due to its screening process which can heighten fear in patients who are worried about developing RMC, thus causing more problems.

With this understanding, Dr. Msaouel lays down steps patients can take for early detection. First, patients must know whether they carry the sickle cell trait or not. Second, if blood is present in the urine, going to see a doctor immediately for further testing. Third, if you are indeed diagnosed with RMC, it’s important to contact physicians who are dedicated to treating this cancer. Lastly, get in touch with patient advocates and communities so you are not alone. This network not only supports patients with RMC but can connect them with specialists such as Dr. Msaouel and others for optimal levels of care.

Dr. Msaouel concludes that early detection can be hopeful. He testifies that some patients who were afflicted with RMC have lived up to 7 years cancer free. Researching RMC for better outcomes is a goal Dr. Msaouel and physicians alike are working towards.

Renal medullary carcinoma,Dr. Pavlos Msaouel,University of Texas MD Anderson Cancer Center,early detection of RMC

About this expert

Pavlos Msaouel, MD, PhD

University of Texas, MD Anderson Cancer Center

Department of Genitourinary Medical Oncology, Division of Cancer Medicine

Transcript

Rebecca Law:
Dr. Msaouel, what steps can be taken for earlier detection of Renal Medullary Carcinoma?


Dr. Pavlos Msaouel
So, the question of earlier detection is a difficult question of course because we are still gathering data. It is not an easy thing to detect this cancer early, and it always comes with pros and cons when you are trying to do more screening for things. Because the problem is that sometimes being too scared about something that may happen to you may end up causing more problems than good -- more harm than good. So, we have to be careful with what recommendations we give. I would say though that -- at the very least -- that it's important to know whether you carry the sickle cell trait or not.


Dr. Pavlos Msaouel:

If you have the sickle cell disease, you will know it, but if you have the trait very often you may not know this so, that's number one -- knowing whether you have the trait or not id important, and many people who have the trait live very normal lives with no issues. However, at the same time it is important to highlight that the sickle cell trait is not completely benign, it is associated with certain risks -- RMC is one of them. So, knowing about that is important and if you know that you carry the trait and you are starting to have blood in your urine then taking that seriously can help diagnose this earlier, diagnose RMC earlier. 


Dr. Pavlos Msaouel

Sometimes this blood or this odd color in the urine may not be blood actually, but taking it seriously and going to a doctor is going to be important and at the same time once you are diagnosed it is important to try and get in touch with people in the community, physicians who are dedicated to treating this cancer  --- and so, we have a network of clinicians, physicians overall, researchers and other people who are very passionate about helping individuals with RMC. So, doing that early and getting in touch with them will be very helpful. At the same time it will also be helpful if you get in touch with a patient community so if you do have RMC, you are not alone. 


Dr. Pavlos Msaouel:

There are other people, both them and their families that have been afflicted by this disease and what I have seen happen is that when people who are diagnosed with this disease -- wherever they are in the world -- get in touch with these patient advocates and patient communities that helps them. Because they know how to get them in touch with people like us, they know how to guide them from a different level -- you know how it is, challenging from a psychological and psychosocial perspective, guide them through this very tough and challenging point in their lives. And I did mention -- and it is true -- that the vast majority of patients will unfortunately present with stage 4 disease that has spread, but there is always hope. So, it is a challenging cancer. I am not sugarcoating it at all, but at the same time there is hope. We have had patients that were afflicted by this disease and are now alive for 6 or 7 or more years, cancer free. So, we have been able to achieve that for some patients and our goal -- and that's what we're working towards and that's what we're doing research for is to one day be able to achieve that for everybody.

Rebecca Law

Rebecca graduated from University of San Francisco with a degree in applied economics, focusing on marketing, program management and event management. Her experience is unmatched when it comes to aligning program scope with strategic business objectives. Rebecca has an extensive background in managing marketing campaigns and is highly skilled at communicating with a variety of audiences.

Related Content

pavlos_msaouel.jpg.resize.405.575_edited

Are Sickle Cell Disease Patients More Susceptible to Renal Medullary Carcinoma?

Dr. Pavlos Msaouel of The University of Texas MD Anderson Cancer Center discusses whether patients with sickle cell disease or who carry the sickle cell trait may be at increased risk for renal medullary carcinoma (RMC).

pavlos_msaouel.jpg.resize.405.575_edited

Can Patients and Providers Eliminate Health Inequities in Treating Sickle Cell Disease?

Dr. Andrew Campbell shares how communities, patients, and providers can eliminate health inequities in Sickle Cell Disease (SCD). He asserts that awareness of SCD in the general population can secure resources and funding. Dr. Campbell emphasizes we investigate why adult and pediatric patients are receiving different levels of care.

pavlos_msaouel.jpg.resize.405.575_edited

What Can Communities Do To Eliminate Disparities in Sickle Cell Disease?

Dr. Ify Osunkwo shares how we can combat disparities in sickle cell disease. Communities need to understand that Sickle Cell Disease (SCD) is genetic. Stop shaming and blaming patients. They need support and understanding. Not just providers need education, but also school, financial, and disability systems.

The information on Diverse Health Hub is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the expert advice of your healthcare team.